Physician profile
Patrick David Swihart
NPI 1568087278
$2,185.58
in general payments reported to CMS, 2019-2025
14 companies · $785 in 2025
The $785 reported for 2025 was more than what 87% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $106 · 2022: $210 · 2023: $411 · 2024: $673 · 2025: $785.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,869.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,869.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $616.00 | 2023-2025 | Infuse, Alden Scleral Zenlens, Miebo |
| Alcon Vision LLC | $432.37 | 2021-2025 | Precision7, Clareon, Precision 1 |
| Coopervision INC. | $214.53 | 2022-2025 | Myday Contact Lens, Clariti Contact Lens |
| Oyster Point Pharma, INC. | $202.37 | 2022-2024 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $167.01 | 2024 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $126.95 | 2021-2025 | Cequa |
| Rxsight INC | $108.79 | 2024 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Glaukos Corporation | $91.95 | 2025 | Istent Infinite, Idosetr |
| Maculogix, INC. | $53.84 | 2021 | |
| Biotissue Holdings INC. | $49.00 | 2024-2025 | |
| Sight Sciences, INC. | $46.46 | 2022 | |
| Lkc Technologies, INC. | $38.00 | 2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $19.57 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $18.74 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Swihart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.